Ordering Recommendation

Use for initial comprehensive testing to aid in the diagnosis and differentiation of skin and mucosal disorders that present with blistering, eczema, erosions, pruritus, and/or urticaria. Use to assess suspected epithelial antibody-associated immunobullous diseases (pemphigoid, pemphigus, and their variants), that are not clinically distinguishable, have nonspecific features, may express overlapping epithelial antibodies, and/or are indicated by concurrent Direct Immunofluorescence, Tissue Biopsy (Cutaneous, Mucosal, Epithelial) (0092572). Preferred panel to assess for epithelial antibodies as a side effect of immune checkpoint inhibitor (anti-PD-1, anti-PD-L1) therapy. 

If dermatitis herpetiformis is suspected, order with Celiac Disease Reflexive Cascade, Serum (3016817) and Epidermal Transglutaminase (eTG/TG3) Antibody, IgA by ELISA (2010902). 

For more information about components, methodology, and specimen type, refer to the ARUP Immunobullous Disease Testing Comparison tool.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Plain red or serum separator tube (SST).

Specimen Preparation

Transfer 2 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated/ambient

Unacceptable Conditions

Hemolyzed or lipemic specimens. Plasma.

Remarks

As a general rule, serum specimens should be shipped to the laboratory as soon as possible. Store refrigerated unless shipping promptly (within 2 hours). Transport at ambient temperature to arrive within 7 days. If 7-14 days until received in laboratory, store and ship refrigerated. If greater than 14 days, serum specimens must be stored and shipped frozen.

Stability

Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely

Methodology

Semi-Quantitative Indirect Immunofluorescence (IIF)/Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)

Performed

Varies

Reported

3-9 days

Reference Interval

By report

Interpretive Data

Refer to report

Compliance Category

Performed by non-ARUP Laboratory

Note

For specimens less than 0.5 mL, call the Immunodermatology Laboratory at 801-581-7139.

Hotline History

N/A

CPT Codes

88346; 88350 x5; 83516 x5

Components

Component Test Code* Component Chart Name LOINC
3001665 Immunobullous Disease Panel
3001666 EER Immunobullous Disease Panel
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • atypical epithelial antibody-associated disease
  • basement membrane zone antibody-associated disease
  • Brunsting-Perry cicatricial pemphigoid
  • Brunsting-Perry pemphigoid
  • bullous disease of childhood
  • bullous lupus erythematosus
  • bullous pemphigoid
  • bullous pemphigoid antigen 1 or BPAg1, BP230
  • bullous pemphigoid antigen 2 or BPAg2, NC16A, BP180
  • bullous systemic lupus erythematosus
  • cell surface antibody-associated disease
  • childhood immunobullous disease
  • chronic bullous disease of childhood
  • cicatricial pemphigoid
  • collagen type 17
  • collagen type XVII
  • dermal basement membrane zone (floor) antibodies with split skin substrate
  • desmoglein 1
  • desmoglein 3
  • desmosomal protein antibodies
  • desmosome antibodies
  • endemic pemphigus
  • epidermolysis bullosa acquisita
  • epithelial antibody-associated disease
  • epithelial basement membrane zone antibody-associated disease
  • epithelial cell surface antibody associated disease
  • fogo selvagem
  • hemidesmosomal protein antibodies
  • hemidesmosome antibodies
  • ICS antibodies
  • IgA mucous membrane pemphigoid
  • IgA pemphigus
  • IgA variant epidermolysis bullosa acquisita (EBA)
  • IgG pemphigus variant
  • IgG variant pemphigus
  • IgG/IgA basement membrane zone antibodies
  • immunobullous disease of childhood
  • Immunobullous Disease Panel, Epithelial
  • indirect fluorescence assay
  • indirect fluorescent antibody (IFA)
  • indirect immunofluorescent assay
  • intercellular IgG/IgA dermatosis
  • intercellular substance antibodies
  • intraepidermal neutrophilic IgA dermatosis
  • linear IgA bullous dermatosis
  • linear IgA disease
  • linear IgAG/IgAG bullous dermatosis
  • mixed epithelial antibody-associated disease
  • mixed immunobullous disease of childhood
  • mucous membrane pemphigoid
  • ocular cicatricial pemphigoid
  • pemphigoid variants
  • pemphigus erythematosus
  • pemphigus foliaceus
  • pemphigus variant
  • pemphigus vegetans
  • pemphigus vulgaris
  • salt split skin test
  • salt-split skin floor antibodies
  • salt-split skin roof antibodies
  • subcorneal pustular dermatosis
  • subepithelial immunobullous disease
  • Type VII collagen antibodies, type XVII collagen
Immunobullous Disease Antibody Panel